Investec Bank Plc has filed a Form 8.5 regulatory disclosure relating to share dealings in Advanced Medical Solutions Group Plc (AMS.L) on 2nd October 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank Plc acted in a client-serving capacity during the transactions, serving as Advisor and Joint Broker to Advanced Medical Solutions Group Plc.
The filing confirms that Investec purchased 12,004 ordinary shares in Advanced Medical Solutions Group at a price of 282 pence per unit on the dealing date.
In the same session, Investec sold 15,073 ordinary shares in the company at a price of 282.25 pence per unit.
No cash-settled derivative transactions or stock-settled derivative transactions were reported as part of this particular disclosure filing.
Investec confirmed there are no indemnity or option arrangements, or any agreements or understandings that may serve as an inducement to deal or refrain from dealing.
The bank also stated there are no agreements or understandings relating to voting rights under any option or derivatives referenced to future acquisition or disposal of relevant securities.
The disclosure was formally dated 5th October 2026, with contact details provided for Abhishek Gawde via telephone for any follow-up regulatory enquiries.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service in a timely manner.
Advanced Medical Solutions Group Plc is a specialist medical device company, and its shares trade on the London Stock Exchange under the ticker AMS.L.
Regulatory filings of this type are routine requirements during offer periods, ensuring transparency in market dealings and maintaining investor confidence in the process.
